Oral Oncology is an international interdisciplinary journal which publishes high quality original research, clinical trials and
review articles, editorials, and commentaries relating to the etiopathogenesis, epidemiology, prevention, clinical features, diagnosis,
treatment and management of patients with neoplasms in the head and neck.
Oral Oncology is of interest
to head and neck surgeons, radiation and medical oncologists, maxillo-facial surgeons, oto-rhino-laryngologists, plastic surgeons, pathologists,
scientists, oral medical specialists, special care dentists, dental care professionals, general dental practitioners, public health physicians,
palliative care physicians, nurses, radiologists, radiographers, dieticians, occupational therapists, speech and language therapists,
nutritionists, clinical and health psychologists and counselors, professionals in end of life care, as well as others interested in these
fields.
Basic, translational, or clinical Research or Review papers of high quality and that make a contribution to new knowledge
are invited on the following aspects of neoplasms arising in the head and neck (including lip, tongue, oral cavity, oropharynx, salivary
glands, sinuses, nose, nasopharynx, larynx, skull base, thyroid, and craniofacial region, and the related hard and soft tissues and lymph
nodes):
• Etiopathogenesis: natural history of cancer and pre-cancer; basic pathology, metastatic mechanisms; genetic
changes; cellular and molecular changes; microorganisms; growth factors, adhesion and other molecules
• Epidemiology;
risk factors; biomarkers; protective factors; geographic factors; prevention; screening and intervention
• Clinical features;
orofacial effects of neoplasms at both local and distant sites; tumor staging and grading
• Diagnosis; detection
of cancer and pre-cancer; cellular and molecular markers for diagnosis; advances in imaging and other functional diagnostic
modalities for cancer and pre-cancer
• Management and Prognosis; clinical, cellular and molecular markers for
prognosis; treatment options including surgical, lasers, photodynamic therapy, cryosurgery, micro- vascular and other forms of
surgery, medical, radiotherapy, chemotherapy, immunotherapy, biological and gene therapy advances; molecular targets and new therapeutics
(new cytotonics and molecular-targeted therapies); multimodality treatment; advances in reconstruction and rehabilitation, including
flaps and grafts, alloplasty, bone and connective tissue biology; multidisciplinary teamwork in cancer care and oral health care.
• Quality of life issues; issues of consent; psychosocial aspects; patient and health professional information; patient involvement;
psychological interventions, improving outcomes; the prevention, diagnosis and management of complications, including, pain, hemorrhage,
dysfunction, deformity, osteoradionecrosis, xerostomia, and others; rehabilitation; palliative and end of life care; and support teamwork.
https://www.mea.elsevierhealth.com/oral-oncology-13688375.html109989Oral Oncologyhttps://www.mea.elsevierhealth.com/media/catalog/product/1/3/13688375_3.jpg406406USDInStock <IT>Oral Oncology</IT> is an international interdisciplinary journal which publishes high quality original research, clinical trials and
review articles, editorials, and commentaries relating to the etiopathogenesis, epidemiology, prevention, clinical features, diagnosis,
treatment and management of patients with <B>neoplasms</B> in the <B>head</B> and <B>neck</B>.
<P><IT>Oral Oncology</IT> is of interest
to head and neck surgeons, radiation and medical oncologists, maxillo-facial surgeons, oto-rhino-laryngologists, plastic surgeons, pathologists,
scientists, oral medical specialists, special care dentists, dental care professionals, general dental practitioners, public health physicians,
palliative care physicians, nurses, radiologists, radiographers, dieticians, occupational therapists, speech and language therapists,
nutritionists, clinical and health psychologists and counselors, professionals in end of life care, as well as others interested in these
fields.
<P>Basic, translational, or clinical Research or Review papers of high quality and that make a contribution to new knowledge
are invited on the following aspects of neoplasms arising in the head and neck (including lip, tongue, oral cavity, oropharynx, salivary
glands, sinuses, nose, nasopharynx, larynx, skull base, thyroid, and craniofacial region, and the related hard and soft tissues and lymph
nodes):
<P>• <B>Etiopathogenesis</B>: natural history of cancer and pre-cancer; basic pathology, metastatic mechanisms; genetic
changes; cellular and molecular changes; microorganisms; growth factors, adhesion and other molecules
<BR>• <B>Epidemiology</B>;
risk factors; biomarkers; protective factors; geographic factors; prevention; screening and intervention
<BR>• Clinical features;
<B>orofacial</B> effects of neoplasms at both local and distant sites; tumor staging and grading
<BR>• Diagnosis; <B>detection</B>
of <B>cancer</B> and pre-cancer; cellular and molecular markers for diagnosis; advances in <B>imaging</B> and other functional diagnostic
modalities for cancer and pre-cancer
<BR>• <B>Management</B> and <B>Prognosis</B>; clinical, cellular and molecular markers for
prognosis; <B>treatment</B> options including surgical, lasers, photodynamic therapy, cryosurgery, micro- vascular and other forms of
surgery, medical, radiotherapy, chemotherapy, immunotherapy, biological and gene therapy advances; molecular targets and new therapeutics
(new cytotonics and molecular-targeted therapies); multimodality treatment; advances in reconstruction and rehabilitation, including
flaps and grafts, alloplasty, bone and connective tissue biology; multidisciplinary teamwork in cancer care and <B>oral health care</B>.
<BR>• Quality of life issues; issues of consent; psychosocial aspects; patient and health professional information; patient involvement;
psychological interventions, improving outcomes; the prevention, diagnosis and management of complications, including, pain, hemorrhage,
dysfunction, deformity, osteoradionecrosis, xerostomia, and others; rehabilitation; palliative and end of life care; and support teamwork.
USD00109988Oral Oncology406406https://www.mea.elsevierhealth.com/media/catalog/product/https://www.mea.elsevierhealth.com/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.pngInStockDomestic1 YearIndividual1368-8375JOURNALELSEVIERIN STOCK1368-8375Volumes 88-99journalsJournalsNoNoNoNoPlease SelectPlease SelectPlease Select